Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

Published:2024-01 Issue:1 Volume:19 Page:59-69
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Sunakawa Yu^ORCID,Kuboki Yasutoshi^ORCID,Watanabe Jun^ORCID,Terazawa Tetsuji,Kawakami Hisato^ORCID,Yokota Mitsuru,Nakamura Masato,Kotaka Masahito,Sugimoto Naotoshi,Ojima Hitoshi^ORCID,Oki Eiji^ORCID,Kajiwara Takeshi^ORCID,Yamamoto Yoshiyuki,Tsuji Yasushi,Denda Tadamichi,Tamura Takao,Ishihara Soichiro,Taniguchi Hiroya^ORCID,Nakajima Takako Eguchi^ORCID,Morita Satoshi,Shirao Kuniaki,Takenaka Naruhito^ORCID,Ozawa Daisuke,Yoshino Takayuki^ORCID

Funder

Taiho Pharmaceutical

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11523-023-01027-8.pdf

Reference47 articles.

1. NCCN Clinical Practice guidelines in Oncology: Colon Cancer. 2023. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed 19 May 2023.

2. Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, et al. Trifluridine-tipiracil and bevacizumab in refractory metastatic colorectal cancer. N Engl J Med. 2023;388:1657–67.

3. Mousa L, Salem ME, Mikhail S. Biomarkers of angiogenesis in colorectal cancer. Biomark Cancer. 2015;7:13–9.

4. Ogunwobi OO, Mahmood F, Akingboye A. Biomarkers in colorectal cancer: current research and future prospects. Int J Mol Sci. 2020;21:5311.

5. Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369:1023–34.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma;Cancers;2024-08-27

2. Elucidating the role of angiogenesis-related genes in colorectal cancer: a multi-omics analysis;Frontiers in Oncology;2024-06-19

3. A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G;Targeted Oncology;2024-03